International journal of molecular sciencesHumansMaleMiddle AgedFemaleImmunotherapy
Apheresis CD8+CCR7+CD45RA- T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome.
Iván García de la Torre, Carlota García-Hoz, Fernando Martin-Moro, José Ignacio Fernández-Velasco, Kyra Velázquez-Kennedy, Eulalia Rodríguez-Martín, Alejandro Luna De Abia, Ernesto Roldán, Gemma Moreno Jiménez, Javier López-Jiménez, Luisa María Villar, Roberto Pariente-Rodríguez
Published: 202610.3390/ijms27020866
Abstract
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL); however, a significant proportion of patients fail to achieve a durable response, underscoring the…
Preview only. Read the full abstract at the source